Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 79.78

0.0%

Dec 31 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (1470)	9/20/2007 10:42:25 AM
From: Jibacoa	Read Replies (2) of 3722

EXAS was up 29% earlier, apparently after some comments about its fecal test for colon Ca in an article in Belgium. Subject 51792 The stock needs to close above $4, but the R/R seems reasonable at present levels.<g> bigcharts.marketwatch.com It is now almost 2Yrs since Tin Beyers at the Motley Fool commented on EXAS having a gross margin of 95.4% and mentioned its DNA-based test for colorectal Ca.<g> But EXAS has been trimming its loss in the last few Qs in spite of its lower revenues & it has no significant LTD. The insiders reportedly hold around 10%. siliconinvestor.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next